KIORA PHARMACEUTICALS, INC.

Analyst Reco. Kiora Pharmaceuticals, Inc.

Equities

KPRX

US49721T3095

Delayed Nasdaq Other stock markets 11:10:02 14/05/2024 pm IST			5-day change	1st Jan Change
0.505 ^USD	-0.92%		+0.80%	-3.33%

10/05	Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M	MT
25/03	Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2 From $3.50, Maintains Buy Rating	09/02	MT
HC Wainwright Adjusts Kiora Pharmaceuticals' Price Target to $3.50 From $2, Keeps Buy Rating	06/11	MT
HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2 From $7, Keeps Buy Rating	14/23/14	MT
HC Wainwright Raises Kiora Pharmaceuticals' Price Target to $7 From $6, Maintains Buy Rating	12/23/12	MT
Maxim Upgrades Kiora Pharmaceuticals to Buy From Hold, Price Target is $12	09/23/09	MT
Ladenburg Thalmann Reiterates Kiora Pharmaceuticals at Buy With $119 Price Target	08/23/08	MT
HC Wainwright Reiterates Kiora Pharmaceuticals at Buy With $10 Price Target	08/23/08	MT
Ladenburg Thalmann Initiates Kiora Pharmaceuticals at Buy With $6.50 Price Target	25/22/25	MT
Maxim Group Downgrades Kiora Pharmaceuticals to Hold From Buy	15/22/15	MT
HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2.50 From $3, Reiterates Buy Rating	11/22/11	MT
HC Wainwright Adjusts Kiora Pharmaceuticals Price Target to $3 From $5, Maintains Buy Rating	19/22/19	MT
Maxim Starts Kiora Pharmaceuticals at Buy With $2.50 Price Target	19/22/19	MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Price Target on Eyegate Pharmaceuticals to $11 From $14, Maintains Buy Rating	16/21/16	MT
EYEGATE PHARMACEUTICALS : Alliance Global Securities Adjusts Eyegate Pharmaceuticals PT to $10.75 From $10.25, Maintains Buy Rating	18/21/18	MT
EYEGATE PHARMACEUTICALS : Alliance Global Partners Adjusts Eyegate Pharmaceuticals PT $10.25 From $16.75, Maintains Buy Rating	31/21/31	MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Eyegate Pharmaceuticals' Price Target to $14 From $10, Keeps at Buy	22/20/22	MT
EYEGATE PHARMACEUTICALS : Alliance Global Partners Adjusts Eyegate Pharmaceuticals PT to $15.50 From $9.50, Maintains Buy Rating	22/20/22	MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Eyegate Pharmaceuticals' Price Target to $10 From $12, Keeps Buy Rating	12/20/12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW